Physician Assistant in Edinburgh, IN Accepting Medicare
2 Physician Assistant nurses found. Showing 1 - 2
 Richard Molinski, P.A. Physician Assistant Medicare: Medicare Enrolled Practice Location: Camp Atterbury, 7812 Msu Det 1, Edinburgh, IN 46124 Phone: 270-304-6571 |
Mr. Peter Gregory Iaria, P.A.-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: Camp Atterbury Troop Medical Clinic, Building 2, Edinburgh, IN 46124 Phone: 812-526-1120 |
News Archive
Researchers identify new regulatory pathway that may play vital role in basal-like breast cancer
Researchers have identified a new regulatory pathway that may play an important role in basal-like breast cancer (BLBC), a particularly aggressive form of breast cancer often referred to as "triple negative." This pathway may serve as a target for the development of an effective therapeutic.
FTC/TDF tablet reduces HIV infection among high-risk individuals: iPrEx study
In a finding with the potential to fundamentally change strategies to slow the global HIV epidemic, a new study called iPrEx shows that individuals at high risk for HIV infection who took a single daily tablet containing two widely used HIV medications, emtricitabine and tenofovir (FTC/TDF), experienced an average of 43.8% fewer HIV infections than those who received a placebo pill. New England Journal of Medicine, is the first evidence that this new HIV prevention method, called pre-exposure prophylaxis or PrEP, reduces HIV infection risk in people.
Researchers study demographic, socioeconomic factors that buffer effects of video game violence
In November 2010, an online gaming company called ActiVision released Call of Duty: Black Ops, a violent, first-person shooter game compatible with a variety of gaming devices. The video game sold 5.6 million copies within 24 hours of its release, and it earned a record-breaking $650 million in its first five days. Six weeks later, the game had exceeded $1 billion in sales.
Vitamin D receptor gene variant protects against male LUTS
An international research effort aimed at identifying the genetic basis of lower urinary tract symptoms has identified five candidate genes, one of which – encoding the vitamin D receptor – is consistently protective against these symptoms in men.
Recordati, Nymox sign European licensing agreement for BPH investigational drug, NX-1207
Recordati and Nymox Pharmaceutical Corporation announced today the signing of a European licensing agreement for the development and commercialization of NX-1207, Nymox's Phase III investigational drug currently in clinical development in the U.S. for the treatment of benign prostatic hyperplasia (BPH).
› Verified 1 days ago